Open an account

ProtoKinetix

PKTX · OTC

$0.0004+$0.0002 (+100.00%)TodayMarket closed ·
No price history for this range.

About PKTX

Protokinetix, Inc. is a research and development stage biotechnology company engaged in the scientific medical research of anti-aging glycoproteins. The company is headquartered in Dalton, Ohio. The company went IPO on 2002-01-07. Company is focused on scientific medical research of Anti-Freeze Glycoproteins (AFGPs) or anti-aging glycoproteins. The firm's anti-aging glycopeptide is for ophthalmology, dermatology, transplant support and biomanufacturing. The commercial applications for AAGPs include various health care solutions. The firm has not developed a commercially viable product and has not generated any revenue.

Employees
0
Headquarters
Dalton, Ohio
Listed
Jan 7, 2002
Sector
Health Care
Industry
Biotechnology
Website
protokinetix.com

PKTX key statistics

Market cap
82.43K
Price-earnings ratio
0.00
Dividend yield
—
Average volume
70.08K
Volume
550.00K
Open price
$0.0004
High today
$0.0004
Low today
$0.0004
52 Week high
$0.0124
52 Week low
$0.0001

ProtoKinetix (PKTX) at a glance

ProtoKinetix (PKTX) last traded at $0.0004, with a market cap of 82.43K and a price-to-earnings ratio of 0.00.

Volume so far is 550.00K shares, above the average of 70.08K shares a day.

Over the past year ProtoKinetix has ranged from $0.0001 to $0.0124, and now sits 2% of the way up that range.

Similar companies

Companies in the same industry as ProtoKinetix

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.